Competitive Landscape of COVID-19 Therapies

Evaluation of COVID-19 Developmental Pipeline Therapies
Objective :

COVID-19 developmental pipeline assessment, identifying key competitors, and evaluating emerging therapies in the domain.

Problem Statement:

A mid-sized EU-based firm involved DelveInsight in assessing the developmental pipeline of COVID-19 to assess the competitors across the clinical development pipeline. They wished to identify and evaluate emerging therapies, key competitors and assess the landscape based on the mechanism of action, route of administration, and others of the emerging candidates.

Our Methodology:
  • Therapeutic R&D Developmental Pipeline Assessment
  • Assessment of the Drugs
  • Key Pharmaceuticals Portfolio Assessment
  • Strategic Planning Assistance
  • Detailed profiling of Active Products in the Pipeline
  • Landscape analysis of various Mechanisms of Action and Routes of Administration
  • Matrix Analysis positioned the top 10 Companies researched.
  • The client can appraise all the top companies that can serve as a potential competition

Related Insights

In-Licensing Opportunity
In-Licensing Opportunity

A large client based in USA, involved in drug delivery devices, with effective marketing and commercialization presence across the globe [...]

View Case
Epidemiology Assessment
Epidemiology Assessment

A client based in the US wanted the epidemiology assessment exercise to understand the percentage of solid organ transplant recipients who develop Cutaneous Squamous Cell Carcinoma... [...]

View Case
Market Size & Forecast Assessment
Market Size & Forecast Assessment

European-based Medical Device Company wanted to understand the complete landscape in regard to current available Patient Pool, Devices Market Size and Competitor Share for Patent... [...]

View Case

Fill the form to download the case study

I consent to DelveInsight gathering details provided via this form. Check our Privacy Policy to know more.